NASDAQ Companies

SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced the initiation of LELANTOS, a Phase 3, […]

NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline […]

Reduction in DUX4-driven gene expression observed in biopsies with highest baseline levels of DUX4-driven gene expressionTopline data on-track for Q1 […]

SHANGHAI, China, Aug. 11, 2020 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI), a leading online entertainment […]

Preliminary Data Demonstrates Normalization of CSF GBA1 Enzyme Activity in Parkinson’s Disease with GBA1 Mutations and Neuronopathic Gaucher Disease PatientsCompany […]

CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that […]

CAMBRIDGE, Mass., and ROSTOCK and BERLIN, Aug. 11, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused […]

CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a […]

Continued progress in the AFM13 pTCL REDIRECT monotherapy studyAFM24 is recruiting patients in cohort 2 of a Phase 1/2a clinical […]

~ No Clinical Safety or Efficacy Issues Identified, and No Requirement for Further Clinical Data ~~ FDA Pre-Approval Inspection has […]